Related Experiment Video
Updated: May 21, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
[Congenital heart diseases in clinical practice]
Carlo Ratti1, Benedetta Veronesi, Laura Grassi
1Unità Operativa di Cardiologia, Osperdale Santa Maria Bianca, Mirandola (Modena), Italy. ratticarlo@hotmail.com
Congenital heart diseases are structural heart abnormalities present at birth, affecting 8 in 1,000 newborns. These conditions range from simple to complex and are classified as cyanotic or not cyanotic.
Area of Science:
- Cardiology
- Genetics
- Pediatrics
Background:
- Congenital heart diseases (CHDs) are structural heart abnormalities present at birth.
- CHDs affect approximately 8 out of every 1,000 newborns globally.
- Some CHDs are linked to underlying genetic disorders.
Purpose of the Study:
- To provide a comprehensive overview of congenital heart diseases.
- To discuss the prevalence and classification of CHDs.
- To highlight the association between CHDs and genetic factors.
Main Methods:
- Literature review of congenital heart disease research.
- Analysis of epidemiological data on newborn heart defects.
- Classification of CHDs based on clinical presentation.
Main Results:
- Congenital heart diseases encompass a spectrum of structural defects.
- Prevalence data indicates 8 per 1,000 live births are affected by CHDs.
- CHDs are broadly categorized into cyanotic and non-cyanotic types.
Conclusions:
- Congenital heart diseases represent a significant public health concern in newborns.
- Understanding the genetic basis of CHDs is crucial for diagnosis and management.
- Effective classification aids in clinical decision-making and treatment strategies for CHDs.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Heart Failure III: Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
Heart Failure II: Pathophysiology

